DIN 02493225 — BALVERSA 4 MG
BALVERSA is a tablet of Erdafitinib marketed by JANSSEN INC. The full Erdafitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02493225
- Brand name
- BALVERSA
- Active ingredient
- Erdafitinib
- Strength
- 4 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Erdafitinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02493217 | BALVERSA | 3 MG | TABLET | JANSSEN INC | MARKETED |
| 02493233 | BALVERSA | 5 MG | TABLET | JANSSEN INC | MARKETED |